The largest database of trusted experimental protocols

7 protocols using pcmv gag pol

1

Generation of SNX1 and SNX5 Rescue Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate SNX1 rescue and SNX5 rescue HT1080 cells, retrovirus particles were prepared by transfecting HEK293T cells with pQCXIP-HA-SNX1 (WT, BT*, SAH* or BT-SAH*) or pQCXIP-HA-SNX5 (WT, BT*, SAH* or BT-SAH*) and retrovirus-packaging plasmids pCMV-Gag-Pol (Cell Biolabs, RV-111) and pCMV-VSV-G (Cell Biolabs, RV-110) using Lipofectamine 3000 (Thermo Fisher Scientific, L3000015) according to the manufacturer’s instructions. Medium was collected 24 h after transfection and centrifuged for 10 min at 1,000 × g to remove debris. The double SNX1-2 KO or double SNX5-6 KO HT1080 cells were immediately infected with the corresponding virus, and stably transduced cells were selected with 2 μg ml−1 puromycin.
+ Open protocol
+ Expand
2

Generation of NDUFB4 Overexpressing Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable cells were generated by retroviral transduction through subcloning into the MSCV-PIG vector (Addgene Plasmid #18751). Synthetic complementary DNA corresponding to human NDUFB4 (NM_004547.6), or modified with N24A and R30A substitutions were purchased from GenScript. Gibson assembly (New England Biolabs, E5510S) was performed to ligate complementary DNA constructs to XhoI/HPAI restriction digested and agarose gel purified MSCV-PIG vector. Resulting bacterial clones were verified to contain the insert using Sanger sequencing with the following primer: 5′-CCCTTGAASSTCCTCGTTCG-3′. Bacterial clones were amplified using the PureLink HiPure Plasmid Midiprep Kit (Invitrogen). Packaging plasmids pCMV-VSVG and pCMV-Gag-Pol (Cell biolabs, inc), and the backbone constructs were cotransfected into unmodified HEK293T cells using Lipofectamine LTX reagent (Thermo Fisher Scientific) in a 1:2:3 ratio. Forty-eight hours posttransfection, viral supernatant was harvested and filtered through a 0.45 μm filter. One milliliter of viral supernatant was combined with 400,000 NDUFB4-KO cells and 8 μg/ml hexadimethrine bromide (polybrene) and centrifuged at 800g for 1 h. Cells were then incubated with viral supernatant for 48 h, followed by replacement media supplemented with 2 μg/ml puromycin. To increase expression, cell lines required an additional round of retroviral transduction.
+ Open protocol
+ Expand
3

Lentiviral CRISPR Construct Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single guide RNAs (sgRNAs, Supplementary Table 2) were designed using the VBC score sgRNA prediction tool82 (link) and cloned into a lentiviral vector enabling expression of the sgRNA and IRFP670 (pLenti-hU6-sgRNA-PGK-IRFP670). The ABCC1 overexpression construct was a gift from Scott Dixon83 (link). For the reconstitution experiment, silent point mutations were introduced into the ABCC1 cDNA using PCR mutagenesis to avoid targeting by ABCC1 sgRNAs and the product was cloned into a pMSCV-PGK-BlastR retroviral expression vector using Gateway cloning. The psPAX2 (Addgene plasmid #12260) and pMD2.G (Addgene plasmid #12259) were gifts from Didier Trono. pCMV-gag/pol was acquired from Cell Biolabs, San Diego, USA.
+ Open protocol
+ Expand
4

Engineered Retroviral Expression System for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
pNGL, pΙκΒαDN, and pCAG.LUC (#74409) have been described elsewhere8 (link),25 (link),33 (link). Lentiviral shRNA pools (Santa Cruz) are described in Supplementary Table 8. A pMIGR1-based (#27490) bicistronic retroviral expression vector was generated by replacing eGFP sequences with puromycin resistance gene (#58250). KrasG12C,Chuk, Ikbkb, Ikbke, and Tbk1 cDNAs were cloned via reverse transcriptase-PCR (RT-PCR) from LLC or MC38 RNA using specific primers (Supplementary Table 6) and were subcloned into peGFP-C1 (Takara, Mountain View, CA). eGFP, eGFP.KrasG12C, eGFP.Chuk, eGFP.Ikbkb, eGFP.Ikbke, and eGFP.Tbk1 cDNAs were subcloned into the new retroviral expression vector (#58249, #64372,# 87033, #58251, #87444, and #87443, respectively). Retroviral particles were obtained by co-transfecting HEK293T cells with retroviral vectors, pMD2.G (#12259), and pCMV-Gag-Pol (Cell Biolabs, San Diego, CA) at 1.5:1:1 stoichiometry using CaCl2/BES. After 2 days, culture media were collected and applied to cancer cells. After 48 h, media were replaced by selection medium containing 2–10 μg/mL puromycin. Stable clones were selected and subcultured11 (link). For stable plasmid/shRNA transfection, 105 tumor cells in six-well culture vessels were transfected with 5 μg DNA using Xfect (Takara), and clones were selected by G418 (400–800 μg/mL) or puromycin (2–10 μg/mL).
+ Open protocol
+ Expand
5

Generating Retroviral Particles for USP10 Knockout

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retroviral particles were prepared by transfecting HEK293T cells with pQCXIP-MYC-USP10, pCMV-Gag-Pol (Cell Biolabs, RV-111), and pCMV-VSV-G (Cell Biolabs, RV-110) plasmids. After 48 h, supernatants were collected and centrifuged at 3000 x g to remove cell debris. USP10-KO H4 cells were infected with virus supernatants in the presence of 5 μg/ml Polybrene at 37 °C. Four hours after infection, the supernatants were aspirated and replaced with fresh culture medium, and cells were incubated at 37 °C overnight. The stably transduced USP10-KO cells were selected with 1 μg/ml puromycin.
+ Open protocol
+ Expand
6

Generation and Purification of PAWS1 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
A PAWS1 antibody was generated by injecting GST-PAWS1 (amino acids 715–815) into sheep. The P-PAWS1 S610 antibody was generated by injecting peptide GPGPRRPS*VAS (* denotes phospho-Ser) into rabbit. The antibodies were subsequently affinity purified. Anti-FLAG-M2-horseradish peroxidase (HRP) antibody was from Sigma. HA-HRP antibody was from Roche. Antibodies recognizing phospho-SMAD1/5/8, phospho-SMAD2, phospho-SMAD3, SMAD2/3, GAPDH and lamin A/C were from Cell Signalling Technology. HRP-conjugated secondary antibodies and light-chain-specific HRP-conjugated antibodies were from Jackson Laboratories. BMP-2 and BMP-4/7 were from R&D Systems. The nuclear cytoplasmic extraction kit was from Thermo Scientific. The first strand cDNA synthesis kit was from Invitrogen. 2X SYBR green master mix was from BioRad. pBABE-Puro, pCMV-Gag-Pol and pCMV-VSVG constructs were from Cell Biolabs. All plasmids for mammalian cell expression were cloned into pCMV5, pBABE-Puro or pcDNA-FRT-TO vectors with N-terminal FLAG, HA or GFP tags as indicated. For bacterial expression of proteins, SMAD1, SMAD2 and PAWS1 (523-end; other mutants) were cloned into pGEX6T vectors. All DNA constructs were verified by DNA sequencing (by the DNA Sequencing Service at University of Dundee; www.dnaseq.co.uk). Bacterial protein expression in BL21 cells and purification were performed as described previously [31 (link)].
+ Open protocol
+ Expand
7

Gene Trap Mutagenesis Protocol for KBM-7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The gene-trap retrovirus used for mutagenesis of KBM-7 cells were generated by co-transfecting HEK293T cells with the green fluorescent protein (GFP) carrying gene-trap vector pGT-GFP, in addition to the packaging plasmids pCMV-Gag-Pol (CellBiolabs), pAdVAntage (Promega) and pCMV-VSV-g (CellBiolabs). Transfection of plasmids was done with the cationic liposome lipofectamine 2000 (Invitrogen). After transfection, culture supernatant containing viral particles was collected and concentrated by centrifugation. The retroviral particles carrying a gene trap cassette with an adenoviral splice-acceptor site, a SV40 polyadenylation signal, and a GFP marker gene were used to infect, and mutagenize the haploid KBM-7 cells in the presence on 8 μg/mL protamine sulfate. After infection with the retroviral particles cells were seeded in 24-well plates and centrifuged for 45 min at 2000 rpm. Fluorescence-activated cell sorting (FACS)-based enrichment (FACSAria II system, BD Biosciences) of infected KBM-7 cells were performed to increase the proportion of mutagenized cells. Screens were started with either freshly mutated cells, or stocks of cells frozen at least 3–4 days after mutagenesis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!